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Summary: Disease mapping focuses on learning about areal units presenting high relative risk. Disease mapping
models for disease counts specify Poisson regressions in relative risks compared with the expected counts. These models
typically incorporate spatial random effects to accomplish spatial smoothing. Fitting of these models customarily
computes expected disease counts via internal standardization. This places the data on both sides of the model, i.e.,
the counts are on the left side but they are also used to obtain the expected counts on the right side. As a result,
these internally standardized models are incoherent and not generative; probabilistically, they could not produce the
observed data. Here, we argue for adopting the direct generative model for disease counts. We model disease incidence
instead of relative risks, using a generalized logistic regression. We extract relative risks post model fitting. We also
extend the generative model to dynamic settings. We compare the generative models with internally standardized
models through simulated datasets and a well-examined lung cancer morbidity data in Ohio. Each model is a spatial
smoother and they smooth the data similarly with regard to relative risks. However, the generative models tend to
provide tighter credible intervals. Since the generative specification is no more difficult to fit, is coherent, and is at
least as good inferentially, we suggest it should be the model of choice for spatial disease mapping.
Key words: Attaching uncertainty; conditionally autoregressive models; internal standardization; logistic regres-
sion; relative risk; spatial smoothing
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1. Introduction
The mapping of disease incidence and prevalence has a long history in public health and
epidemiology (see, e.g., Lawson et al. (2000); Best et al. (2005); Koch (2005); Leyland and
Davies (2005)). A primary objective in disease mapping analysis is to examine the spatial
patterns of disease, which can help identify high-risk areas and better allocate health care
resources.
Customary disease mapping models assume the disease counts are distributed as Poisson
random variables. For any count, the mean is specified as the product of the expected
disease count and relative risk. The expected disease counts are taken as fixed and known
quantities, and the relative risks are modeled using generalized linear regressions. Typically,
spatial random effects are incorporated to accomplish spatial smoothing of the relative risks.
To compute the expected disease counts, a common practice is internal standardization,
calculating the expected disease counts as functions of the observed numbers of cases.
However, this implies that the data appear on both sides of the model, resulting in a
probabilistically incoherent specification. Such models are not generative; probabilistically,
they could not produce the data we observe.
The contribution of this paper is to argue on behalf of adopting a coherent generative
model specified through disease incidence rather than relative risk, avoiding internal stan-
dardization. Inference regarding relative risks arises as a post model fitting activity. We
introduce spatial smoothing using the usual conditionally autoregressive (CAR) model. We
also extend the generative model to dynamic settings. We compare the generative models
with internally standardized models through simulated datasets and also a real dataset.
We find that, by virtue of the flexibility enabled for the random effects under the CAR
model, the internally standardized model and the generative model yield little difference in
the point estimation of relative risks. In different words, each model is a spatial smoother
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and the models smooth the data similarly. However, the generative model tends to provide
tighter credible intervals. We illuminate these results through simulation studies along with
an application to a widely investigated dataset on lung cancer mortality in Ohio (Waller
et al. 1997; Xia et al. 1997; Knorr-Held and Besag 1998; Knorr-Held 2000; Kottas et al.
2008). We also show that model fitting for the generative model is no more difficult than
for the usual internally standardized model. Therefore, because it is coherent and is at least
as good inferentially, we suggest that it should be the model of choice for spatial disease
mapping.
There is a large literature on disease mapping over the past three decades. It essentially
dates to Clayton and Kaldor (1987), who built Bayesian Poisson regressions with random
intercepts to capture spatial association across relative risks. Besag et al. (1991) split relative
risks into different components and present a fully Bayesian framework, which is easily
extended to handle more complex settings. Examples include dynamic models considering
spatiotemporal effects (Waller et al., 1997; Xia et al., 1997; Kottas et al., 2008) and multi-
variate models focusing on regional counts of multiple diseases (Knorr-Held and Best, 2001;
Carlin and Banerjee, 2003; Gelfand and Vounatsou, 2003; Held et al., 2005). Again, within
this broad literature, the basic formulation models relative risks, using internal standard-
ization to compute the expected disease counts. Therefore, these extensions suffer from the
incoherency problem; all can be revised using a generative specification. In particular, we
present an illustrative dynamic extension.
Again, in modeling either relative risks or disease incidence, we introduce spatial random
effects for smoothing. The most commonly used prior for spatial random effects is the
conditional autoregressive (CAR) specification (Clayton and Kaldor 1987; Besag et al. 1991;
Waller et al. 1997; Knorr-Held and Besag 1998; Banerjee et al. 2014). By defining “neighbors”
for each region, the spatial random effects borrow strength locally and thus smooth the
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local rates toward their neighboring values. Richer CAR-type models are available (see, e.g.,
Halloran and Berry (2000); Leroux et al. (2000); MacNab and Dean (2000); White and Ghosh
(2009)) and can be incorporated in our generative specification. Here we confine ourselves
to the basic CAR model.
The structure of the paper is as follows. Section 2 reviews the internally standardized
model and introduces the coherent generative model. Section 3 presents model comparison
on simulated data. Section 4 presents real data analysis, on both cross-sectional settings and
dynamic settings. Section 5 concludes with brief discussion.
2. Modeling details
2.1 The Internally Standardized Model
Suppose for a set of regions i = 1, ..., I, partitioning a study domain, we observe disease
counts Yi as well as a set of region-specific covariates Xi. Let pi be the true incidence for
region i and p¯ be the overall disease rate across the entire study domain. The goal of disease
mapping is to infer about the relative risk of the disease, ri = pi/p¯, for each region. Usually
we assume the number of units at risk in each region, ni, is fixed and known and, therefore,
p¯ =
∑
i nipi∑
i ni
. For rare diseases, it is reasonable to use the Poisson approximation to the
binomial distribution. The standard model in the literature becomes (Clayton and Kaldor,
1987; Besag et al., 1991),
Yi | ri ind∼ Po(Eiri),
log(ri) = X
′
iβ + φi, (1)
where the φi’s are region-specific random effects, and Ei is the expected number of cases
under a null model such as constant risk for all units. The inference goals are to learn about
the β’s but also to implement smoothing of the ri through the φi. While smoothing is desired,
there is no notion of a “best” smoothing, making model comparison difficult in this regard.
4 ,
For many datasets, the Ei are computed via internal standardization (IS) as
Ei = ni ˆ¯p = ni
∑
i Yi∑
i ni
, (2)
and are treated as fixed. We refer to Model (1) as the IS model and, in the sequel, we
denote ri in (1) as r
(IS)
i . To incorporate spatial correlation, hence spatial smoothing, across
the regions, it is usually assumed that the φi’s follow a conditional autoregressive (CAR)
distribution (Waller et al., 1997; Banerjee et al., 2014):
p(φ1, φ2, ..., φI | τ) ∝ τ I2 exp{−τ
2
I∑
i=1
∑
j<i
wij(φi − φj)2}, (3)
where wij = 1 if region j is adjacent to region i and wij = 0 otherwise. Centering is
implemented to identify the φi’s so
∑
i φi = 0.
Since the model in (1) is hierarchical, it is often fitted within a Bayesian framework. Vague
Normal and gamma priors are usually assigned to the β’s and τ , respectively. Below we take
pi(β) ∝ 1 and τ ∼ Gamma(1,1). The model is usually fit using Markov chain Monte Carlo
(MCMC) (Besag et al., 1991).
A concern regarding the IS model is that it is not generative because one cannot obtain the
Ei’s before Yi’s are realized. In different words, internal standardization implicitly imposes
outcome information on both sides of the regression specification, rendering the model
probabilistically incoherent. Also, while sensible smoothing may arise from an IS model,
failure to acknowledge the uncertainty in the computed Ei’s can lead to unsatisfactory
assessment of uncertainty in inference, as we show below.
A more satisfying approach to compute Ei is through external standardization, that is, to
use an outside data source such as statewide or nationwide data for incidence. However, such
data may not exist or, if it does, when the resulting Ei’s arise from a different population,
collected over a different domain, at a different time, employing them with the r
(IS)
i ’s, for
the study population in the IS model can still be problematic. An overview of arguments for
and against standardization can be found in Waller and Gotway (2004, Chapter2).
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2.2 A Coherent Generative Model
We propose a generative Poisson model for disease mapping with a specification for pi rather
than ri:
Yi | pi ind∼ Po(nipi),
logit(pi) = X
′
iβ + φi, (4)
where, again, the random effects, the φi’s, follow a CAR distribution. We adopt the same
priors for the β and τ as in the IS model. The model in (4) can also be fitted straightforwardly
using MCMC. It can be viewed as directly applying a Poisson approximation to a binomial
model for each region. Additionally, (4) avoids internal standardization and is coherent; we
refer to it as the CG (coherent generative) model hereafter.
If we define r˜i = nipi/Ei with Ei as above, then we can recover smoothed r˜i’s as a post
model fitting exercise. The ri are a linear transformation of the pi and the posterior samples
of the pi immediately provide posterior samples for the r˜i. In fact, the ‘true” ri are such
that ri =
pi
p¯
where, again, p¯ =
∑
i nipi∑
i ni
. So, the smoothed true ri can also be recovered post
model fitting. Posterior samples of the pi will provide posterior samples of the ri but now
the transformation is nonlinear. In the sequel we denote these two choices of relative risks
as r˜
(CG)
i and r
(CG)
i . Again, r˜
(CG)
i =
pi
ˆ¯p
while r
(CG)
i =
pi
p¯
. Below, we compare the inference
regarding these relative risks along with the r
(IS)
i .
We offer a simple illumination of the adjustment provided by the spatial random effects. In
the CG model, pi =
exp(X′iβ+φi)
1+exp(X′iβ+φi)
. Let pi,non =
exp(X′iβ)
1+exp(X′iβ)
and ηi = e
φi , then we can rewrite pi
as pi =
pi,non
pi,non+(1−pi,non)/ηi . Values of the ηi’s determine the degree of spatial smoothing of the
pi’s: there is no smoothing of pi’s when ηi = 1 (corresponding to φi = 0); pi’s are smoothed
upward when ηi > 1 and downward when ηi < 1. Similarly in the IS model, we can write
ri = ηiri,non, where ri,non = exp(X
′
iβ); the values of the ηi’s play a similar role in smoothing
the ri’s.
6 ,
If we summarize the relative risks in terms of posterior means, we find the following.
Let η
(IS)
i = e
φ
(IS)
i . Then, E(r
(IS)
i |data) = E(η(IS)i exp{X′iβ(IS)}|data). Similarly, let η(CG)i =
eφ
(CG)
i . Given that exp{X′iβ(CG) + φ(CG)i } is usually small, we have
E(r˜
(CG)
i |data) ≈
ni
Ei
E(η
(CG)
i exp{X′iβ(CG)}|data).
The flexibility in scaling of the η’s suggests that there will be little difference in these two
estimated relative risks.
Because of the nonlinear form in the pi’s, E(r
(CG)
i |data) is difficult to accurately assess
analytically. However, its behavior can be quite different from E(r˜
(CG)
i |data). For example, if
the model for pi is logit(pi) = β0, i.e., pi is constant over all regions, then r
(CG)
i = 1 for all i, re-
gardless of the data. When a constant pi model is inappropriate for the data, then, evidently,
it is an inappropriate model for learning about relative risk. However, E(r˜
(CG)
i |data) =
E( e
β0
1+eβ0
|data)/ ˆ¯p, which need not be close to 1 but will be close to E(r(IS)i |data). The
posterior variances for these relative risks are not accessible analytically but are examined
in the simulation and data analysis examples below.
Rates of disease incidence, the pi’s, are often very small and therefore link functions
distinguishing small probabilities may be more appropriate than the standard logit link.
Therefore, we investigated two alternative links – the complementary log-log (c-loglog) link,
which approaches 0 fairly slowly,
pi = 1− exp{− exp(X′iβ + φi)}, (5)
and the skewed logit link,
pi =
c0{exp(X′iβ + φi)}
1 + c0 exp(X′iβ + φi)
, (6)
which, for suitable c0, rises faster than the usual logit and thus also may help to distinguish
small values better.
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2.3 Dynamic Model Specifications
The CG model can be readily extended to dynamic settings, where the primary objective
is to explain the spatiotemporal patterns of disease and perhaps to make (smoothed) fore-
casts of future disease risks. However, smoothed prediction implies that accurate future
prediction is not an objective. In building such spatiotemporal models, one needs to specify
spatial effects, temporal effects and their interactions. A variety of formulations have been
proposed, including additive models (Knorr-Held and Besag, 1998), multiplicative models
(Bernardinelli et al., 1995; Xia et al., 1997), independent CAR models for different time
periods (Waller et al., 1997), or the general spatiotemporal autoregressive (STAR) models
(Pace et al., 2000). Illustratively, we consider a simple additive model for the spatiotemporal
effects without interaction, where the temporal random effects follow an AR(1) model and
the spatial random effects follow a CAR model. Letting Yit be the disease counts for region
i at time t for i = 1, ..., I and t = 1, ..., T , the dynamic CG model is,
Yit ∼ Po(nitpit),
logit(pit) = X
′β + φi + αt,
αt = ραt−1 + δt,
(φ1, φ2, ..., φI) ∼ CAR(τ), (7)
again with pi(β) ∝ 1, τ ∼ Gamma(1, 1), and δt ∼ N(0, ω) with pi(ρ, ω) ∝ ω−1.
For comparison, we can also extend the IS model to a similar dynamic setting:
Yit ∼ Po(Eitrit)
log(rit) = X
′β + φi + αt (8)
with the same AR(1) model for the temporal effects αt and CAR model for the spatial
effects φi as in the CG model (7). Similarly to the above, the expected disease counts Eit
are calculated via internal standardization at each time as Eit = nit
∑
i Yit/
∑
i nit.
8 ,
3. Simulation examples
3.1 Simulation Design
We design our simulation investigation based upon a real application which we take up in
Section 4 – the lung cancer mortality data from the state of Ohio. The data was originally
extracted from a public use database (Centers for Disease Control, 1988) for every county
in the United States. It has been widely studied in disease mapping (Waller et al., 1997; Xia
et al., 1997; Knorr-Held and Besag, 1998; Knorr-Held, 2000; Kottas et al., 2008). In Section
4 we focus on a subset of I = 88 Ohio counties over a period of T = 21 years (from 1968 to
1988), yielding a total of 7392 observations.
For our simulation, we use the same geographical map of the 88 Ohio counties and the
population data for the year 1988. To somewhat mimic the real spatial scenario, we assign the
“true” incidence rates pi for these counties as follows: we first set pi = 0.001 for all counties,
and then for the three most populated counties, Cuyahoga county (containing Cleveland),
Franklin county (containing Columbus) and Hamilton county (containing Cincinnati), we
assign higher incidence rates by increasing pi by 0.0015, 0.001 and 0.001 respectively. Finally
for all adjacent counties of these three counties, we increase pi by 0.0005. Figure 1 depicts
the resulting map of the true pi’s.
[Figure 1 about here.]
Using these assigned values of pi’s and the true ni’s in the real Ohio data, we generate Yi
from Po(nipi). We repeated this B = 500 times to create 500 simulated datasets.
3.2 Comparison Criteria
For model comparison, we focus on inference regarding the ri’s – the main objective in the IS
model. We compare the point estimates of the two models using two loss functions motivated
by counts: the relative squared error, ratio(r) = (rˆi − ri)2/ri, and the squared bias of the
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logarithm of the ri’s, bias(r) = {log(rˆi)− log(ri)}2. We also compare the empirical coverages
and lengths of the nominal 90% credible intervals to evaluate the uncertainty of the estimates
from each model.
Note that since smoothing is the goal of the disease mapping modeling, it is not sensible
to assess model performance in terms of recovery of the raw counts or rates; we could
achieve this perfectly without smoothing. Rather, we need to think about performance in
the sense of shrinkage estimation (Efron and Morris, 1973, 1997), i.e., in terms of expected
loss for estimating the vector of mean relative risks. That is, we know that, in three or more
dimensions, certain shrinkage estimators dominate the maximum likelihood estimators in
terms of risk for certain choices of loss functions. For count data, the foregoing choices are
suitable to consider.
As a result, for loss function, L(rˆi, ri) where ri is the true relative risk, we need to study
E(
∑
i L(rˆi, ri)), the overall expected loss, for an estimator {rˆi, i = 1, 2, ..I}. We can do
this through simulation, i.e., by obtaining a Monte Carlo integration for the expectation,
through generation of samples under a specific set {pi, i = 1, 2...I} (which induces a set of
ri’s), computing the loss for each sample and averaging over the samples. In this regard, out
of sample prediction in space or time is not an appropriate way to assess the performance of
a finite dimensional model whose intent is smoothing.
3.3 Simulation Results
We first present results from a randomly chosen single simulated dataset. Figure 2 displays
the spatial surfaces of the three ri’s estimated from the two models incorporating spatial
effects. As expected, the spatial maps are nearly identical, with counties around Cuyahoga,
Franklin and Hamilton having higher relative risks than the others. An exception is Lorain
(see Figure 1), which is identified as one of the high risk counties (ri > 1) by using r
(CG)
i ,
but not the case by using r
(IS)
i and r˜
(CG)
i . As Lorain has very high risk with true relative
10 ,
risk being 1.023, this suggests that the CG model with estimator r
(CG)
i may be better in
discovering high risk counties.
[Figure 2 about here.]
To further examine the smoothing performance, we show shrinkage for each of the three
estimators in Figure 3. In each shrinkage plot, we compare the model estimates incorporating
spatial effects with the MLE estimates Yi/Ei. We find the three shrinkage plots are nearly
identical, and all of them have substantially shrunk the model estimates towards the grand
mean for the counties with very low or high MLE estimates.
[Figure 3 about here.]
We then compare the three estimators along with the MLE estimates through expected
loss, which is calculated using the 500 replicated samples. The expected losses for r
(IS)
i , r˜
(CG)
i ,
r
(CG)
i and Yi/Ei are 0.5486, 0.5490, 0.5485, and 1.3268 respectively when using ratio(r); the
corresponding expected losses are 0.7375, 0.7378, 0.7371 and 2.0364 when using bias(r).
Though the three model estimates show no distinguishable differences, they all substantially
outperform the MLE estimates.
Next, we compare inference under the three model estimates in terms of uncertainty. For
a given model, each of the 500 samples provides a 90% credible interval for the relative risk
for each of the 88 counties. Each interval yields a length and a binary variable recording
whether it contained the true value (1) or not (0). Hence, we can create a 500 × 88 matrix
of lengths as well as a 500× 88 matrix of binary outcomes. We can examine these matrices
by rows, by columns, or overall. We seek to compare them across the results for the three
model estimates. Summary results are present in Table 1. Under the actual population sizes,
the ni’s, and the usual logit link, the resulting expected coverage probabilities, averaged over
the 88 counties, exceed the nominal probabilities for each of the three estimators. They are
94.39%, 94.47% and 94.14% and the overall average length are 0.2538, 0.2537 and 0.2517,
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respectively. To make row-wise comparison for the two CG model estimators with the IS
model, we calculate the percentage of time (out of 500 replications) the CG interval was
shorter than the IS model. For r˜
(CG)
i we find 51% of their average intervals are shorter than
r
(IS)
i , while for r
(CG)
i , we find 95.2% are shorter than r
(IS)
i . To make column-wise comparison
for the two CG model estimators with the IS model, we calculate the proportion of times
(out of 88) the CG interval was shorter than the IS model. For r˜
(CG)
i we find 48.86% of
their average intervals are shorter than r
(IS)
i , while for r
(CG)
i we find 88.64% shorter than
r
(IS)
i . These findings suggest that the CG model with estimator r
(CG)
i tends to achieve tighter
credible intervals than the IS model, while r˜
(CG)
i and r
(IS)
i do not show much difference.
[Table 1 about here.]
We then replace the usual logit link with the c-loglog link and with the skewed logit link;
the results are also shown in Table 1. For the skewed logit link, we set c0 = 0.004 to make
it favor small probabilities. Under the population size ni, the c-loglog link and the skewed
logit link yield similar results to those for the usual logit link. The resulting averages of the
expected coverage probabilities are all around 94%. With regard to the length of credible
intervals, r˜
(CG)
i and r
(IS)
i are comparable, but r
(CG)
i tends to result in shorter intervals than
r
(IS)
i in both row-wise and column-wise comparison.
To consider sensitivity to population sizes, we reduce the actual size of ni to ni/10 and
then redo the entire simulation exercise. As shown in Table 1, it seems that now the resulting
expected average of the coverage probabilities rises to roughly 97%. Also, regardless of the
links, r
(CG)
i leads to tighter credible intervals than r
(IS)
i , with both the row-wise and column-
wise proportions around 90%. The estimator r˜
(CG)
i behaves similarly to r
(IS)
i . This suggests
robustness of the performance of the CG model to the population size.
12 ,
4. Application to the Ohio cancer mortality data
4.1 Cross-sectional settings
We now apply the two models with spatial random effects, yielding three estimators, to
analyze the Ohio lung cancer mortality data. For the static analysis we consider relative
risks for the first and last years, 1968 and 1988. Figure 4 presents maps of the raw estimates
(Yi/Ei) and the three model estimates of the ri’s in the two specific years, respectively.
For each year, the spatial estimates of the models are nearly identical and all three reveal
the smoothing of the raw rates. Counties with extreme raw relative risks are smoothed by
their neighbors. An example is Paulding county (see Figure 1), which has a high raw rate in
year 1968 but is adjacent to several low risk counties; due to the spatial effects, the models
substantially reduce the estimated relative risk for this county.
[Figure 4 about here.]
The CG model with estimator r
(CG)
i results in tighter credible intervals than the IS model
in 62 and 60 out of the 88 counties in year 1968 and 1988, respectively. For r˜
(CG)
i , the number
of shorter credible intervals than the IS model is only 50 and 49 out of the 88 counties in
year 1968 and 1988, respectively. In particular, visible from Figure 5, the CG model with
estimator r
(CG)
i tends to produce shorter intervals for several counties located in northeastern
and southern Ohio.
[Figure 5 about here.]
4.2 Dynamic settings
We fit the two dynamic models to the Ohio data consisting of T = 21 years, one for the full
dataset and one for the subset of white males between 55 and 64 years (Knorr-Held, 2000;
Kottas et al., 2008). Holding out year 1988, we fit models for the 20 years from 1968 to 1987.
We assess model performance for those 20 years and then make predictions for relative risks in
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year 1988. Perhaps the most important finding is the magnitude of ρˆ in Table 2. Particularly
for the full dataset, there is very strong first order temporal correlation. To assess the benefit
of the spatio-temporal model, we consider year 1987. We first compare the lengths of 90%
credible intervals of the three estimators, say r
(IS)
i , r˜
(CG)
i and r
(CG)
i , in dynamic models. We
find the dynamic CG model with estimator r
(CG)
i again tends to provide tighter intervals
for the ri’s than the IS model: 57 and 55 out of the 88 counties for the full dataset and the
subset, respectively. The estimator r˜
(CG)
i is comparable to r
(IS)
i ; only 45 and 42 out of the
88 counties have shorter intervals for the full dataset and the subset, respectively.
We then compare the results for the dynamic model with those for the static model for year
1987; the results are shown in Table 2. For each of the three estimators, the dynamic models
yield smaller average length of credible intervals than the static models. Also, when making
a pair-wise comparison for each county, all the 88 counties have tighter credible intervals
from the dynamic models than from the static models. These findings suggest that gathering
20 years of data into the dynamic models reduces uncertainty relative to that for the single
year static models.
Because the goal of dynamic models is to provide explanation and smoothing in space
and time rather than prediction, we provide prediction results solely for information. We use
both predictive mean square error (PMSE) and continuous rank probability scores (CRPS)
(Gneiting and Raftery, 2007) to compare the predicted values and predictive distributions
with the observed raw risks. We also examine the length of 90% credible intervals and their
coverage for the observed raw rates. As shown in Table 2, the three estimators r
(IS)
i , r˜
(CG)
i
and r
(CG)
i result in similar MSE and CRPS values, and the coverage rates are all very low.
[Table 2 about here.]
We select two counties in the subset to display the spatiotemporal effects. One is Hamilton,
a highly populated county located in southwestern part of the state, and the other is
14 ,
Delaware, more suburban and located in central Ohio. Figure 6 presents the estimated
relative risks and their 90% credible intervals obtained from the CG model using estimator
r
(CG)
i for year 1968 to 1988. For both counties, the dynamic CG model has smoothed the
raw rates to suggest an increasing trend in relative risk over time.
[Figure 6 about here.]
5. Discussion
For specifying disease mapping models, we have argued that the usual internally standardized
(IS) model is not generative, incoherent and tends to provide overestimation of uncertainty
in inference. Toward this issue, we have proposed a coherent generative (CG) model, which
models incidence, pi, instead of relative risk, ri, to avoid internal standardization. The
generative model enables two relative risk estimators. With regard to smoothing, estimators
from the internally standardized model as well as the two estimators using the coherent
specification yield essentially indistinguishable results. We provide some analytical support
in this regard as well as a simulation study. However, the posterior estimator for the relative
risk, as a parametric function under the coherent model, tends to provide tighter credible
intervals than that for the IS model both in simulation studies and the real data analysis. The
CG model can be extended to richer model settings. We illustrated with a simple dynamic
version; its benefit in estimation of uncertainty still holds.
A future direction is to extend the single disease modeling to multiple diseases modeling.
For example, let pij denote the incidence rate for disease j in region i. The logit transforma-
tion of pij can be modeled as logit(pij) = X
′
ijβj + φij, where φij’s are spatial random effects
with a multivariate conditional autoregressive (MCAR) prior. Another future possibility is to
employ the richer CAR-type models mentioned in the Introduction with the CG specification.
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Appendix
Posterior computation for the coherent generative model (4)
Letting φ = (φ1, φ2, ..., φI)
T , the joint posterior is
f(φ, β, τ | n,Y ,X, a, b) ∝ {
I∏
i=1
f(Yi | ni,Xi, β, φi)}f(φ | τ)f(τ | a, b)f(β). (A.1)
The likelihood function is
I∏
i=1
exp
[
− ni
1 + exp{−(X′iβ + φi)}
] [
ni
1 + exp{−(X′iβ + φi)}
]Yi
/Yi!. (A.2)
The resulting full conditional distributions are as follows:
a. f(φi | ·) ∝ exp(− τwi+2 (φi− φ¯i)2− ni1+exp{−(X′iβ+φi)} −Yi log[1 + exp{−(X
′
iβ+φi)}]), where
wi+ =
∑I
j=1wij and φ¯i =
∑
j wijφj/wi+;
b. f(β | ·) ∝ exp(−∑Ii=1 ni1+exp{−(X′iβ+φi)} +∑Ii=1 Yi log[ ni1+exp{−(X′iβ+φi)} ]);
c. f(τ | ·) ∼ Gamma{a+ I
2
, b+ 1
2
∑I
i=1
∑
j<iwij(φi − φj)2}.
For φi, i = 1, 2, .., I and β, we use a Metropolis step to update. Specifically, we begin with
a univariate version of this algorithm, in which the proposal distribution for each target
variable is a univariate normal candidate density centered at the current value and having
18 ,
some variance σ2. Then σ2 is tuned to provide the Metropolis acceptance ratio between 15%
to 40%.
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Figure 1. Map of the true disease incidence pi in the simulation study.
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Figure 2. Maps of three estimators of the logarithm of ri’s. (a, b, c represent r
(IS)
i , r˜
(CG)
i
and r
(CG)
i respectively.)
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Figure 3. Shrinkage plots for three estimators of the logarithm of ri’s. (a, b, c represent
r
(IS)
i , r˜
(CG)
i and r
(CG)
i respectively. In each panel, the upper points represent the model
estimates, while the lower points represent the MLE estimates.)
22 ,
          (a)                       (b)                       (c)                       (d) 
 
 
 
(e)                       (f)                       (g)                       (h) 
  
 
 
 
 
 
 
Figure 4. Maps of different estimators of the ri’s (in logarithm) for Ohio data in year
1968 and 1988. (a, b, c d are raw rates, r
(IS)
i , r˜
(CG)
i and r
(CG)
i for year 1968; e, f, g, h are
corresponding values for year 1988.)
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Figure 5. Maps of the length of 90% credible intervals of the ri’s for Ohio data in year
1968 and 1988. (a, b, c are r
(IS)
i , r˜
(CG)
i and r
(CG)
i for year 1968, and d, e, f are those for year
1988.)
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Hamilton Delaware 
Figure 6. The point estimates (solid lines) and 90% interval estimates (dotted lines) of
relative risks using r
(CG)
i over time for two selected counties. In each figure, the circles denote
the raw rates for year 1968 to 1977, and the “∗” denotes the raw rates for year 1988.
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Table 1
Simulation results of three estimators, under different population size and different links.
Population Link Estimator
Average of 500× 88 % (CI(CG) < CI(IS))
Coverage Length Row-wise Column-wise
ni
usual logit
r
(IS)
i 94.39% 0.2538 − −
r˜
(CG)
i 94.47% 0.2537 51.00% 48.86%
r
(CG)
i 94.14% 0.2517 95.20% 88.64%
c-loglog
r
(IS)
i 94.25% 0.2536 − −
r˜
(CG)
i 94.37% 0.2538 42.75% 31.82%
r
(CG)
i 94.00% 0.2517 93.25% 87.50%
skewed logit
r
(IS)
i 94.15% 0.2538 − −
r˜
(CG)
i 94.27% 0.2541 41.60% 34.09%
r
(CG)
i 94.10% 0.2519 93.20% 86.36%
ni/10
usual logit
r
(IS)
i 97.54% 0.5568 − −
r˜
(CG)
i 97.49% 0.5567 52.00% 55.68%
r
(CG)
i 97.19% 0.5512 90.40% 97.73%
c-loglog
r
(IS)
i 97.50% 0.5583 − −
r˜
(CG)
i 97.50% 0.5583 50.20% 52.27%
r
(CG)
i 97.20% 0.5528 89.00% 95.45%
skewed logit
r
(IS)
i 97.34% 0.5564 − −
r˜
(CG)
i 97.34% 0.5566 49.40% 40.91%
r
(CG)
i 97.04% 0.5512 88.00% 94.32%
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Table 2
Results for dynamic analysis of the Ohio data (D and S present dynamic and static models)
Dataset Estimator ρˆ
Length of CIs (1987) Prediction (1988)
Avg.(D) Avg.(S) % (D<S) PMLE CRPS Coverage
Full
r
(IS)
i 0.9344 0.2743 0.3940 100% 0.2204 0.2327 39.77%
r˜
(CG)
i 0.9341 0.2749 0.3972 100% 0.2206 0.2327 40.91%
r
(CG)
i 0.9341 0.2746 0.3948 100% 0.2206 0.2327 40.91%
Subset
r
(IS)
i 0.7569 0.3818 0.5936 100% 0.4967 0.5034 38.64%
r˜
(CG)
i 0.7686 0.3838 0.6025 100% 0.4966 0.5032 38.64%
r
(CG)
i 0.7686 0.3847 0.6114 100% 0.4966 0.5032 38.64%
